ASSOCIATION OF ANTI-DOUBLE STRANDED DNA ANTIBODIES, C-REACTIVE PROTEIN, AND ERYTHROCYTE SEDIMENTATION RATE FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN TAMIL NADU.

Authors

  • Natesan Manikandan Department of Microbiology and Biotechnology, Presidency College, Chennai, Tamil Nadu, India.
  • Marimuthu Ragavan Rameshkumar Department of Microbiology and Biotechnology, Presidency College, Chennai, Tamil Nadu, India.
  • Rajeshwari S Department of Rheumatology,Rajiv Gandhi Government General Hospital, Chennai, Tamil Nadu, India.
  • Narasingam Arunagirinathan Department of Microbiology and Biotechnology, Presidency College, Chennai, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i1.21670

Keywords:

Anti-double stranded DNA antibody, C-reactive protein, Erythrocyte sedimentation rate, Systemic lupus erythematosus

Abstract

 Objective: To determine the serum levels of anti-double stranded DNA (anti-dsDNA) antibodies, serum C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) in patients with systemic lupus erythematosus (SLE) from Tamil Nadu, and elucidate their correlation level.

Methods: Blood samples were collected from 100 SLE patients (mean age 39 years) attended to the Rheumatology Care Centre, Rajiv Gandhi Government General Hospital, Chennai. Anti-dsDNA antibodies IgG in SLE patients were analyzed by Enzyme-linked Immunosorbent Assay, and CRP was measured by turbidimetry. ESR was measured by Westergren method.

Results: In a total of 100 SLE patients, 72 cases were positive for anti-dsDNA antibody. The mean level of anti-dsDNA antibodies in 72 SLE patients was 102 IU/ml. Among the 100 SLE cases, 92 cases (92%) had elevated levels of CRP and their mean level was 11 ± 4 mg/L. The mean ESR levels were high in SLE patients (56 ± 20 mm/hr). Significant association of anti-dsDNA antibodies with ESR (r = 0.357; p < 0.001) and CRP (r = 0.81; p = 0.023) was found.

Conclusion: Anti-dsDNA antibodies had a significant association with CRP and ESR. The result of our study suggests an association of anti-dsDNA antibodies with ESR and CRP and was linked with SLE disease progression.

 

Downloads

Download data is not yet available.

References

Walport MJ. Lupus, DNase and defective disposal of cellular debris. Nat Genet 2000;25:135-6.

Keerthana PC, Anila KN. Carbamazepine-induced SLE-A rare and serious ADR. Int J Pharm Pharm Sci 2017;9:319-20.

Ronnblom L, Alm GV. Systemic lupus erythematosus and the Type I interferon system. Arthritis Res Ther 2003;5:68-75.

Pradhan V, Rajadhyaksha A, Patwardhan J, Surve P. High sensitivity C-reactive protein (hsCRP): Association with clinical subsets in systemic lupus erythematosus (SLE) patients from Western India. Indian J Rheumatol 2013;8:65-7.

Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell

;130:25-35.

Kumar A. Indian guidelines on the management of SLE. J Indian Rheumatol Assoc 2002;10:80-96.

Rahman A, Isenberg DA. Review article: Systemic lupus erythematosus. N Engl J Med 2008;358:929-39.

Hegazy A, Barakat AF, Gayyar E, Arafa LF. Prevalence and clinical significance of anti-C1q antibodies in cutaneous and systemic lupus erythematosus. Egypt J Med Hum Genet 2012;13:167-71.

Keenan RT, Swearingen CJ, Yazici Y. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients. Clin Exp Rheumatol 2008;26:814-9.

Malaviya AN, Chandrasekaran AN, Kumar A, Shamar PN. Systemic lupus erythematosus in India. Lupus 1997;6:690-700.

Habib HM, Arafat WR, Marie MA, Eissa AA. Pulmonary involvement in early systemic lupus erythematosus. Egypt Rheumatol 2013;35:225-31.

Shah D, Sah S, Wanchu A, Wu MX, Bhatnagar A. Altered redox state and apoptosis in the pathogenesis of systemic lupus erythematosus. Immunobiology 2013;218:620-7.

Mok CC, Birmingham DJ, Ho LY, Herbert LA, Rovin BH. High sensitivity C-reactive protein, disease activity and cardiovascular risk factors in systemic lupus erythematosus. Arthritis Care Res 2013;65:441-7.

Gheita TA, El-Gazzar II, Askalany G, El-Fishawy HS, El-Faramawy A. High sensitivity C-reactive protein (hs-CRP) in systemic lupus erythematosus without cardiac involvement; Relation to disease activity, damage and intima-media thickness. Egypt Rheumatol 2012;34:147-52.

Witte T, Hartung K, Matthias T, Sachse C, Fricke M, Deicher H. Association of IgA anti-ds DNA antibodies with vasculities and disease activity in systemic lupus erythematosus. SLE study group. Rheumatol Int 1998;18:63-9.

Published

01-01-2018

How to Cite

Manikandan, N., M. R. Rameshkumar, R. S, and N. Arunagirinathan. “ AND ERYTHROCYTE SEDIMENTATION RATE FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN TAMIL NADU”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 1, Jan. 2018, pp. 214-6, doi:10.22159/ajpcr.2018.v11i1.21670.

Issue

Section

Original Article(s)